Two Sigma Advisers
CKPT

Two Sigma Advisers’s Checkpoint Therapeutics CKPT Stock Holding History

Two Sigma Advisers’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-8,010
Closed -$83K – 2533
2022
Q3 		$83K Sell
8,010
-7,090
-47% -$84.5K ﹤0.01% 2331
2022
Q2 		$156K Sell
15,100
-10,470
-41% -$137K ﹤0.01% 2322
2022
Q1 		$453K Sell
25,570
-1,300
-5% -$27.9K ﹤0.01% 2032
2021
Q4 		$836K Sell
26,870
-15,270
-36% -$506K ﹤0.01% 1651
2021
Q3 		$1.39M Buy
42,140
+11,750
+39% +$347K ﹤0.01% 1455
2021
Q2 		$897K Buy
30,390
+4,620
+18% +$128K ﹤0.01% 1684
2021
Q1 		$809K Buy
25,770
+24,030
+1,381% +$805K ﹤0.01% 1769
2020
Q4 		$46K Buy
+1,740
New +$44K ﹤0.01% 2325

Other funds holding CKPT

TC
TwinBeech Capital Purchase, New York $965M AUM 0.23% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
PAS
Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Advisers's CKPT Position: Q4 2022 in Review

Two Sigma Advisers sold out of Checkpoint Therapeutics (CKPT) in Q4 2022, closing a stake of 8,010 shares — an estimated $83K sold.

Two Sigma Advisers first reported a position in CKPT in Q4 2020 and held it in 8 quarters. The position peaked at $1.39M in Q3 2021. 40 funds tracked by Wall St. Rank hold CKPT as of Q4 2022.

  • Two Sigma Advisers reported no remaining Checkpoint Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 8,010 Checkpoint Therapeutics shares in Q4 2022, an estimated $83K.
  • Two Sigma Advisers first reported a position in Checkpoint Therapeutics in Q4 2020 and held it in 8 quarters.
  • Two Sigma Advisers's Checkpoint Therapeutics position peaked at $1.39M in Q3 2021.
  • 40 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q4 2022.

Based on Two Sigma Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.